Your browser doesn't support javascript.
loading
Evaluation of oncology infusion pharmacy practices: A nationwide survey.
Boyd, A M; Sue, C; Khandoobhai, A; Vinson, B; Shaikh, H; Sorenson, S; Patel, V; Snyder, B; Bondarenka, C; Koukounas, Y; Earl, M; Jenkins, M.
Afiliación
  • Boyd AM; Department of Pharmacy, Cleveland Clinic, Cleveland, OH, USA.
  • Sue C; Department of Pharmacy, UC Health, Cincinnati, OH, USA.
  • Khandoobhai A; Department of Pharmacy, The Johns Hopkins Hospital, Baltimore, MD, USA.
  • Vinson B; Department of Pharmacy, Cedars-Sinai, Los Angeles, CA, USA.
  • Shaikh H; Department of Pharmacy, University Health, Kansas City, MO, USA.
  • Sorenson S; Department of Pharmacy, University of Iowa Health Care, Iowa City, IA, USA.
  • Patel V; Department of Pharmacy, Cedars-Sinai, Los Angeles, CA, USA.
  • Snyder B; Department of Pharmacy, Atrium Health Wake Forest Baptist, Winston-Salem, NC, USA.
  • Bondarenka C; Bristol-Meyers Squibb Company, New York, NY, USA.
  • Koukounas Y; Department of Pharmacy, Medical University of South Carolina, Charleston, SC, USA.
  • Earl M; Department of Pharmacy, Cleveland Clinic, Cleveland, OH, USA.
  • Jenkins M; Novartis, Basel, Switzerland.
J Oncol Pharm Pract ; 30(1): 127-141, 2024 Jan.
Article en En | MEDLINE | ID: mdl-37122190
PURPOSE: Oncology care continues to evolve at a rapid pace including provision of infusion-based care. There is currently a lack of robust metrics around oncology infusion centers and pharmacy practice. The workgroup completed a nationwide survey to learn about oncology-based infusion pharmacy services offered. The objective was to highlight consistent, measureable oncology-based infusion pharmacy metrics that will provide a foundation to describe overall productivity including emphasis on high patient-safety standards. METHODS: A nationwide survey was developed via a workgroup within the Vizient Pharmacy Cancer Care Group beginning in April 2019 and conducted electronically via the Vizient Pharmacy Network from September to November 2020. The survey was designed to capture a number of key metrics related to oncology-based infusion pharmacy services. RESULTS: Forty-one sites responded to the survey. Responses highlighted hours of operation (median = 11.5), number of infusion chairs (median = 45). Staffing metrics included 7.1 pharmacist full-time equivalent (FTE) and 7.6 technician FTE per week. 80.5% of sites had cleanrooms and 95.1% reported both hazardous and nonhazardous compounding hoods. 68.3% of sites reported using intravenous (IV) technology, 50.0% measured turnaround time, and 31.4% prepared treatment medications in advance. CONCLUSION: There was variability among oncology infusion pharmacy practices in regard to survey responses among sites. The survey results highlight the need for standardization of established productivity metrics across oncology infusion pharmacies in order to improve efficiency and contain costs in the changing oncology landscape. The survey provides insight into oncology infusion pharmacy practices nationwide and provides information for pharmacy leaders to help guide their practices.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Farmacias / Farmacia / Servicios Farmacéuticos Tipo de estudio: Guideline / Qualitative_research Límite: Humans Idioma: En Revista: J Oncol Pharm Pract Asunto de la revista: FARMACIA Año: 2024 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Farmacias / Farmacia / Servicios Farmacéuticos Tipo de estudio: Guideline / Qualitative_research Límite: Humans Idioma: En Revista: J Oncol Pharm Pract Asunto de la revista: FARMACIA Año: 2024 Tipo del documento: Article País de afiliación: Estados Unidos